Medicine Overview of Embeta HT Tablet
Nausea, Diarrhoea, Constipation, Fatigue, Headache, Dizziness, Nasopharyngitis (inflammation of the throat and nasal passages), Increased blood uric acid, Decreased potassium level in blood, Glucose intolerance, Altered blood lipids, Cold extremities, Slow heart rate, Decreased magnesium level in blood, Increased calcium level in blood.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Embeta HT 25 mg/12.5 mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
Embeta HT 25 mg/12.5 mg Tablet is a combination of two blood-pressure lowering medicines: Metoprolol Succinate and Hydrochlorothiazide. Metoprolol Succinate is a beta blocker which works specifically on the heart to reduce heart rate and make the heart more efficient at pumping blood throughout the body. Hydrochlorothiazide is a diuretic which lowers blood pressure by removing extra water and certain electrolytes from the body. Over time it also relaxes blood vessels and improves blood flow.
In Depth Information on Embeta HT Tablet
Embeta HT Tablet related warnings
Taking Hydrochlorothiazide with alcohol may have additive effects in lowering blood pressure. You may experience headache, dizziness, lightheadedness, fainting, and/or changes in pulse or heart rate.
WEIGH RISKS VS BENEFITS
Embeta HT 25 mg/12.5 mg Tablet may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Embeta HT 25 mg/12.5 mg Tablet is probably safe to use during lactation.
Limited human data suggests that the drug does not represent a significant risk to the baby.
Embeta HT 25 mg/12.5 mg Tablet may make you feel dizzy, sleepy, tired, or decrease alertness. If this happens, do not drive.
Embeta HT 25 mg/12.5 mg Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Embeta HT 25 mg/12.5 mg Tablet may be needed. Please consult your doctor.
Use of Embeta HT 25 mg/12.5 mg Tablet is not recommended in patients with severe kidney disease.
Embeta HT 25 mg/12.5 mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Embeta HT 25 mg/12.5 mg Tablet may be needed. Please consult your doctor.
One of the following vendor pharmacies will deliver Embeta HT 25 mg/12.5 mg Tablet: HAT, OLT, SSA, DFP, UMP, SRG, MBP, PVP, QTM, OWP, JSL, SMN, PRT, BLS, TRP, AWS, NVY, RDR, NSL, NDP, MPC, SBA, DLP, SHC, TOM, BLP, ENP, AVS, MDH, BAL, LHA, HPC, THP, UBL, VNS, HNP, GTK, OHM, RJH, AGT, MKT, IAD, ESY, DPP, DHP, BAP, MSD, RKS, DVH, CLT, KMC, ATL, SYN, BMJ, PPR, BHM, GHR, BDN, DHR, ZVP, KHH, BNA, HZF, PEN, RSS, GPP, MMS, EAN, STA, ANT, VRS, BHP, KHC, JHC, RSA, PLT, SWP, PHN, AAY, HSP, GTC, WSI, BLE, RPI, AMR, KNH, ABP, HTS, 9MM, ARD, SGC, HBV, DAO, DZY, SGH, SDM, SAF, SVS, RPP, OIP, NXG, HIP, NAS, BIO, ADT, BSN, EVP, SWA, RHL, HEX, RHW, JVN, BBS, JVO, MAK, GNC, EPS, RUS, PWN, VDH, MAX, NNP, UHP, ZEL, SVH, 4IT, VJS, TNH, PTI, QLF, FGH, USF, NVL, MAM, DYG, NTB, ZPR, BTM, AAR, SHD, BBN, TFP, LMS, GPT, 9T9, SJP, KAL, AYU, AYM, PRN, HMP, GBL, WHL, SWT, SCH, SLN, BHS, LCC, JIV, HGI, ATP, ANP, DPL, KIS, MLC, TSS, MDO, SPD, MAP, BHA, SBL, BGS, EMB, JBT, CHP, PNT, RWP, RDH, PMA, EQN, IPL, DGN, NNH